|1.||Teng, Yun: 2 articles (10/2014 - 01/2013)|
|2.||Medjakovic, Svjetlana: 2 articles (10/2014 - 01/2013)|
|3.||Jungbauer, Alois: 2 articles (10/2014 - 01/2013)|
|4.||Klinge, Carolyn M: 2 articles (10/2014 - 01/2013)|
|5.||Kojima, Kaihei: 2 articles (03/2006 - 09/2004)|
|6.||Zoechling, Alfred: 1 article (10/2014)|
|7.||Gerster, Petra: 1 article (10/2014)|
|8.||Gartner, Michael: 1 article (10/2014)|
|9.||Ivanova, Margarita M: 1 article (10/2014)|
|10.||Schildberger, Barbara: 1 article (10/2014)|
|1.||Breast Neoplasms (Breast Cancer)
01/01/2013 - "This study examined the effect of fenhexamid and fludioxonil on the expression of the oncomiR miR-21 in MCF-7, T47D, and MDA-MB-231 human breast cancer cells and downstream targets of miR-21 in MCF-7 cells. "
01/01/2013 - "Endocrine disruptors fludioxonil and fenhexamid stimulate miR-21 expression in breast cancer cells."
01/01/2013 - "Fenhexamid and fludioxonil showed endocrine disruptor activity as antiandrogens in an androgen receptor reporter assay in engineered human breast cancer cells. "
10/01/2014 - "Fludioxonil and fenhexamid were ERα agonists (EC50 -values of 3.7 and 9.0 μM, respectively) and had time-dependent effects on endogenous ERα-target gene expression (cyclin D1, progesterone receptor, and nuclear respiratory factor 1) in MCF-7 human breast cancer cells. "
06/01/2005 - "Fludioxonil at a concentration of 450 mg litre(-1), gave 98 and 92% control of blue mold of apples in the simulated shelf-life studies after CA and common cold storages, respectively. "
06/01/2005 - "Comparison on the effect of fludioxonil in CA storage and common cold storage showed that higher concentrations of fungicide were needed in cold storage than in CA storage. "
06/01/2005 - "At a concentration of 300 mg litre(-1), fludioxonil gave complete control of post-harvest blue mold caused by the thiabendazole-resistant and -sensitive P expansum for 105 days in controlled atmosphere (CA) storage at 2 (+/-1) degrees C, for 42 days in common cold storage at 4 (+/-1) degrees C and also in a shelf-life study for 6 days at 20 (+/-1) degrees C. "
09/01/2004 - "Analysis using a OSC1-GFP fusion gene indicated that Osc1 is rapidly translocated to the nucleus in appressorial cells after the addition of fludioxonil, suggesting that fludioxonil impairs the function of infection structures by activation of Osc1. "
11/01/2006 - "Pyrrolnitrin is the active ingredient of drugs for the treatment of superficial fungal infections and was used as a lead structure for the development of fludioxonil. "
10/01/2006 - "Both infection and ochratoxin A production were reduced when using cyprodinil (37.5%) plus fludioxonil (25%) and azoxystrobin (25%). "
|4.||Wounds and Injuries (Trauma)
|4.||Nuclear Respiratory Factor 1
|6.||Progesterone Receptors (Progesterone Receptor)
|7.||Androgen Receptors (Androgen Receptor)